Contrive Datum Insights has published "Culture Media Market Size, Share & Industry Analysis, By Product type (Dehydrated Culture Media, Ready-to-Use Media, Media Supplements and Additives, Sera, Custom Media), Formulation (Serum-Containing Media, Serum-Free Media, Chemically Defined Media, Protein-Free Media, Animal-Origin-Free Media), Application (Biopharmaceutical Production, Cell and Gene Therapy, Clinical Microbiology Diagnostics, Pharmaceutical Quality Control, Food and Beverage Safety Testing, Environmental and Water Testing, Academic and Basic Research), Cell and organism type (Bacterial, Fungal and Yeast, Mammalian, Insect, Stem Cells, Plant and Algae), Physical form (Powder, Liquid, Semi-Solid Gel, Lyophilized and Tablet), Media function (General-Purpose, Selective, Differential, Enrichment, Chromogenic, Transport), Packaging format (Petri Plates, Tubes and Vials, Bottles, Bags and Bioprocess Containers, Bulk Drums and Sacks), Production scale (Research Scale, Process Development Scale, Commercial Manufacturing Scale), End user (Pharmaceutical and Biotechnology Companies, Contract Research and Manufacturing Organizations, Diagnostic Laboratories and Hospitals, Food and Beverage Manufacturers, Academic and Research Institutes), Distribution channel (Direct Sales, Distributors, Online and E-Commerce), and Regional Forecast, 2026-2034". The study sizes the global culture media market at USD 7.2 billion in 2025 and projects growth from USD 7.84 billion in 2026 to USD 14.62 billion by 2034, a compound annual growth rate of 8.1% across the forecast period.
Culture media are nutrient formulations that let bacteria, fungi, mammalian cells and other organisms grow outside their natural environment. They are supplied as dehydrated powders, ready-to-use liquids, gels, supplements and additives, sera and custom blends, and they serve microbiology testing as well as biologics and cell therapy production. Buyers include biopharmaceutical manufacturers, contract research and manufacturing organizations, diagnostic laboratories, food producers and research institutions.
Biologics manufacturing expansion
Biologics manufacturing expansion is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 8.1% a year, the product type lines exposed to it move fastest: Custom Media compounds at 13.63%, taking its share of revenue from 12% to 19% and its value from USD 0.86 billion to USD 2.78 billion.
Where the forecast could be beaten: biologics and cell therapy pipelines reach commercial scale sooner, serum-free adoption accelerates and single-use bag uptake spreads faster in Asia Pacific. The study puts that case at USD 17.3 billion in 2034, against USD 14.62 billion in the base.
The downside is specific. Cell therapy approvals slip, raw material costs stay high and customers delay media changes because of requalification effort, slowing growth in the advanced segments, and 2034 revenue lands at USD 12.65 billion. Dehydrated Culture Media is the drag, 24% of the 2025 base compounding at 4.64% while the market runs at 8.1%.
Key Players Compete on Media Supplements and Additives Volume and Custom Media Growth
Two positions matter, and they are set by product type. Media Supplements and Additives carries 27% of 2025 revenue (USD 1.94 billion) and is still the largest line in 2034 at 28%, hard to take from an incumbent. Custom Media, at 13.63%, is where the USD 7.2 billion base is redistributed. The two demand different capabilities.
What Else the Report Shows
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Formulation | Serum-Free Media | 28% · USD 2.02 billion | Chemically Defined Media 12.03% |
| Application | Biopharmaceutical Production | 34% · USD 2.45 billion | Cell and Gene Therapy 17.57% |
| Cell and organism type | Mammalian | 42% · USD 3.02 billion | Stem Cells 10.94% |
| Physical form | Liquid | 50% · USD 3.6 billion | — |
| Media function | General-Purpose | 46% · USD 3.31 billion | — |
| Packaging format | Bottles | 36% · USD 2.59 billion | Bags and Bioprocess Containers 16.91% |
| Production scale | Commercial Manufacturing Scale | 48% · USD 3.46 billion | — |
| End user | Pharmaceutical and Biotechnology Companies | 40% · USD 2.88 billion | Contract Research and Manufacturing Organizations 11.76% |
| Distribution channel | Direct Sales | 55% · USD 3.96 billion | Online and E-Commerce 11.39% |
- Regionally, the lead sits with North America: 34% of 2025 global revenue, USD 2.45 billion rising to USD 4.53 billion in 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 29% in 2025 to 35% in 2034, with revenue growing from USD 2.09 billion to USD 5.12 billion.
- Middle East and Africa stays the smallest contributor across the period: 4.5% of revenue in 2025 and 4.5% in 2034.
- Media Supplements and Additives was the leading product type line in 2025, taking 27% of revenue at USD 1.94 billion.
- No product type line grows faster than Custom Media, at a projected 13.63%.
- The United States is the largest single country market at USD 2.15 billion in 2025, 29.86% of global revenue.
Coverage runs to ten axes, by product type, and by formulation, application, cell and organism type, physical form, media function, packaging format, production scale, end user and distribution channel, with a revenue figure and a growth rate for every line in every year from 2020 to 2034, and bear, base and bull cases on the headline total at USD 12.65 billion and USD 17.3 billion by 2034. All five regions are broken out to country level, alongside the competitive landscape and the methodology behind each estimate. The study is delivered as a PDF, and a free sample can be requested.